Aniko Szabo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aniko Szabo has a total of 780 co-authors. Here are the top co-authors by number of shared publications:
- Razelle Kurzrock
Genomic Sciences and Precision Medicine Center, and Medical College of Wisconsin Cancer Center, Milwaukee, WI
23 shared publications - Douglas B. Evans
Department of Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA
22 shared publications - Mandana Kamgar
Mary Ann and Charles LaBahn Pancreatic Cancer Program, Medical College of Wisconsin, Milwaukee, WI 53226, USA
22 shared publications - Mohammed Aldakkak
Medical College of Wisconsin 2 Cancer Center, LaBahn Pancreatic Cancer Program Milwaukee, Wisconsin
22 shared publications - Susan Tsai
The Ohio State University Wexner Medical Center 11 Department of Surgery, James Comprehensive Cancer Center Columbus, Ohio
22 shared publications - Thomas McFall
Department of Biochemistry and MCW Cancer Center, Medical College of Wisconsin, Milwaukee, USA
22 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Elsevier in Blood Neoplasia
Circulating Multiple Myeloma Cell Kinetics and Genomic Profiling Predict Resistance to Targeted Immunotherapies
- 4 November 2026
- Published by Elsevier in Blood Neoplasia
Open AccessCirculating Multiple Myeloma Cell Kinetics and Genomic Profiling Predict Resistance to Targeted Immunotherapies
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S1. Role of KRASMUT-SOS axis in MAPK signaling
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S1. Role of KRASMUT-SOS axis in MAPK signaling
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S2. Ex-vivo organotypic slice culture methodology
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S2. Ex-vivo organotypic slice culture methodology
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S3. RAS inhibitor resistance
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S3. RAS inhibitor resistance
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S5. Characterization of toroid integrity by orthogonal methods
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S5. Characterization of toroid integrity by orthogonal methods
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S4 Patient Tumor Bioprinting
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S4 Patient Tumor Bioprinting
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S6. Sensitivity to trametinib
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer
Figure S6. Sensitivity to trametinib
- Open Access
- 29 October 2026
- Published by Elsevier in Resuscitation
- Vol. 229
Ventilation monitoring in out-of-hospital cardiac arrest care
- 29 October 2026
- Published by Elsevier in Resuscitation
- Vol. 229
Open AccessVentilation monitoring in out-of-hospital cardiac arrest care